Psychodelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment

Visit StreetInsider.com at http://www.streetinsider.com/Hot+List/Psychodelic+stocks+fall+as+FDA+regulatory+advisers+fail+to+back+MDMA-based+PTSD+treatment/23324000.html for the full story.